Squarepoint’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-18,815
| Closed | -$195K | – | 2841 |
|
|
2023
Q3 | $195K | Buy |
+18,815
| New | +$195K | ﹤0.01% | 2122 |
|
|
2023
Q1 | – | Sell |
-12,296
| Closed | -$138K | – | 2652 |
|
|
2022
Q4 | $138K | Sell |
12,296
-22,110
| -64% | -$248K | ﹤0.01% | 1988 |
|
|
2022
Q3 | $381K | Buy |
34,406
+18,529
| +117% | +$205K | ﹤0.01% | 1510 |
|
|
2022
Q2 | $134K | Buy |
+15,877
| New | +$134K | ﹤0.01% | 1832 |
|
|
2021
Q2 | – | Sell |
-11,186
| Closed | -$420K | – | 2935 |
|
|
2021
Q1 | $420K | Sell |
11,186
-17,387
| -61% | -$653K | ﹤0.01% | 1649 |
|
|
2020
Q4 | $949K | Buy |
+28,573
| New | +$949K | 0.01% | 1114 |
|